Selected research
Market Outlook & Growth Opportunities
Global Meso Scale Discovery (MSD) Assay Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Meso Scale Discovery (MSD) Assay Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Meso Scale Discovery (MSD) Assay Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Meso Scale Discovery (MSD) Assay Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Meso Scale Discovery (MSD) Assay Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Meso Scale Discovery (MSD) Assay Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Meso Scale Discovery (MSD) Assay Services market include Chimera Biotec, Reaction Biology, NorthEast BioAnalytical Laboratories LLC, Creative Proteomics, Pestka Biomedical Laboratories, Inc, Precision Medicine Group, LLC, CellCarta, ImmunoDiagnostics Limited and Alcyomics Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Meso Scale Discovery (MSD) Assay Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Meso Scale Discovery (MSD) Assay Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Meso Scale Discovery (MSD) Assay Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Meso Scale Discovery (MSD) Assay Services market.
Meso Scale Discovery (MSD) Assay Services Segment by Company
Chimera Biotec
Reaction Biology
NorthEast BioAnalytical Laboratories LLC
Creative Proteomics
Pestka Biomedical Laboratories, Inc
Precision Medicine Group, LLC
CellCarta
ImmunoDiagnostics Limited
Alcyomics Ltd
IMMUNOLOGIX
Novogene
Guidon Pharmaceutics
MEDx Translational Medicine Co., Ltd
Meso Scale Discovery (MSD) Assay Services Segment by Type
S-Plex Technology
V-Plex Technology
Other
Meso Scale Discovery (MSD) Assay Services Segment by Application
Pharmaceutical Research
Clinical Diagnostics
Biomarker Discovery
Others
Meso Scale Discovery (MSD) Assay Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Meso Scale Discovery (MSD) Assay Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Meso Scale Discovery (MSD) Assay Services key companies, revenue, market share, and recent developments.
3. To split the Meso Scale Discovery (MSD) Assay Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Meso Scale Discovery (MSD) Assay Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Meso Scale Discovery (MSD) Assay Services significant trends, drivers, influence factors in global and regions.
6. To analyze Meso Scale Discovery (MSD) Assay Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meso Scale Discovery (MSD) Assay Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Meso Scale Discovery (MSD) Assay Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meso Scale Discovery (MSD) Assay Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Meso Scale Discovery (MSD) Assay Services industry.
Chapter 3: Detailed analysis of Meso Scale Discovery (MSD) Assay Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Meso Scale Discovery (MSD) Assay Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Meso Scale Discovery (MSD) Assay Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- S-Plex Technology
- V-Plex Technology
- Other
Applications
- Pharmaceutical Research
- Clinical Diagnostics
- Biomarker Discovery
- Others
Companies covered
- Chimera Biotec
- Reaction Biology
- NorthEast BioAnalytical Laboratories LLC
- Creative Proteomics
- Pestka Biomedical Laboratories, Inc
- Precision Medicine Group, LLC
- CellCarta
- ImmunoDiagnostics Limited
- Alcyomics Ltd
- IMMUNOLOGIX
- Novogene
- Guidon Pharmaceutics
- MEDx Translational Medicine Co., Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Meso Scale Discovery (MSD) Assay Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Meso Scale Discovery (MSD) Assay Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Meso Scale Discovery (MSD) Assay Services Market Dynamics
- 2.1 Meso Scale Discovery (MSD) Assay Services Industry Trends
- 2.2 Meso Scale Discovery (MSD) Assay Services Industry Drivers
- 2.3 Meso Scale Discovery (MSD) Assay Services Industry Opportunities and Challenges
- 2.4 Meso Scale Discovery (MSD) Assay Services Industry Restraints
3 Meso Scale Discovery (MSD) Assay Services Market by Company
- 3.1 Global Meso Scale Discovery (MSD) Assay Services Company Revenue Ranking in 2025
- 3.2 Global Meso Scale Discovery (MSD) Assay Services Revenue by Company (2021-2026)
- 3.3 Global Meso Scale Discovery (MSD) Assay Services Company Ranking (2024-2026)
- 3.4 Global Meso Scale Discovery (MSD) Assay Services Company Manufacturing Base and Headquarters
- 3.5 Global Meso Scale Discovery (MSD) Assay Services Company Product Type and Application
- 3.6 Global Meso Scale Discovery (MSD) Assay Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Meso Scale Discovery (MSD) Assay Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Meso Scale Discovery (MSD) Assay Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Meso Scale Discovery (MSD) Assay Services Market by Type
- 4.1 Meso Scale Discovery (MSD) Assay Services Type Introduction
- 4.1.1 S-Plex Technology
- 4.1.2 V-Plex Technology
- 4.1.3 Other
- 4.2 Global Meso Scale Discovery (MSD) Assay Services Sales Value by Type
- 4.2.1 Global Meso Scale Discovery (MSD) Assay Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Meso Scale Discovery (MSD) Assay Services Sales Value by Type (2021-2032)
- 4.2.3 Global Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type (2021-2032)
5 Meso Scale Discovery (MSD) Assay Services Market by Application
- 5.1 Meso Scale Discovery (MSD) Assay Services Application Introduction
- 5.1.1 Pharmaceutical Research
- 5.1.2 Clinical Diagnostics
- 5.1.3 Biomarker Discovery
- 5.1.4 Others
- 5.2 Global Meso Scale Discovery (MSD) Assay Services Sales Value by Application
- 5.2.1 Global Meso Scale Discovery (MSD) Assay Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Meso Scale Discovery (MSD) Assay Services Sales Value by Application (2021-2032)
- 5.2.3 Global Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application (2021-2032)
6 Meso Scale Discovery (MSD) Assay Services Regional Value Analysis
- 6.1 Global Meso Scale Discovery (MSD) Assay Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Meso Scale Discovery (MSD) Assay Services Sales Value by Region (2021-2032)
- 6.2.1 Global Meso Scale Discovery (MSD) Assay Services Sales Value by Region: 2021-2026
- 6.2.2 Global Meso Scale Discovery (MSD) Assay Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Meso Scale Discovery (MSD) Assay Services Sales Value (2021-2032)
- 6.3.2 North America Meso Scale Discovery (MSD) Assay Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Meso Scale Discovery (MSD) Assay Services Sales Value (2021-2032)
- 6.4.2 Europe Meso Scale Discovery (MSD) Assay Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Meso Scale Discovery (MSD) Assay Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Meso Scale Discovery (MSD) Assay Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Meso Scale Discovery (MSD) Assay Services Sales Value (2021-2032)
- 6.6.2 South America Meso Scale Discovery (MSD) Assay Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Meso Scale Discovery (MSD) Assay Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Meso Scale Discovery (MSD) Assay Services Sales Value Share by Country, 2025 VS 2032
7 Meso Scale Discovery (MSD) Assay Services Country-level Value Analysis
- 7.1 Global Meso Scale Discovery (MSD) Assay Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Meso Scale Discovery (MSD) Assay Services Sales Value by Country (2021-2032)
- 7.2.1 Global Meso Scale Discovery (MSD) Assay Services Sales Value by Country (2021-2026)
- 7.2.2 Global Meso Scale Discovery (MSD) Assay Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Meso Scale Discovery (MSD) Assay Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Meso Scale Discovery (MSD) Assay Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Meso Scale Discovery (MSD) Assay Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Chimera Biotec
- 8.1.1 Chimera Biotec Company Information
- 8.1.2 Chimera Biotec Business Overview
- 8.1.3 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
- 8.1.4 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 8.1.5 Chimera Biotec Recent Developments
- 8.2 Reaction Biology
- 8.2.1 Reaction Biology Company Information
- 8.2.2 Reaction Biology Business Overview
- 8.2.3 Reaction Biology Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
- 8.2.4 Reaction Biology Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 8.2.5 Reaction Biology Recent Developments
- 8.3 NorthEast BioAnalytical Laboratories LLC
- 8.3.1 NorthEast BioAnalytical Laboratories LLC Company Information
- 8.3.2 NorthEast BioAnalytical Laboratories LLC Business Overview
- 8.3.3 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
- 8.3.4 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 8.3.5 NorthEast BioAnalytical Laboratories LLC Recent Developments
- 8.4 Creative Proteomics
- 8.4.1 Creative Proteomics Company Information
- 8.4.2 Creative Proteomics Business Overview
- 8.4.3 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
- 8.4.4 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 8.4.5 Creative Proteomics Recent Developments
- 8.5 Pestka Biomedical Laboratories, Inc
- 8.5.1 Pestka Biomedical Laboratories, Inc Company Information
- 8.5.2 Pestka Biomedical Laboratories, Inc Business Overview
- 8.5.3 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
- 8.5.4 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 8.5.5 Pestka Biomedical Laboratories, Inc Recent Developments
- 8.6 Precision Medicine Group, LLC
- 8.6.1 Precision Medicine Group, LLC Company Information
- 8.6.2 Precision Medicine Group, LLC Business Overview
- 8.6.3 Precision Medicine Group, LLC Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
- 8.6.4 Precision Medicine Group, LLC Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 8.6.5 Precision Medicine Group, LLC Recent Developments
- 8.7 CellCarta
- 8.7.1 CellCarta Company Information
- 8.7.2 CellCarta Business Overview
- 8.7.3 CellCarta Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
- 8.7.4 CellCarta Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 8.7.5 CellCarta Recent Developments
- 8.8 ImmunoDiagnostics Limited
- 8.8.1 ImmunoDiagnostics Limited Company Information
- 8.8.2 ImmunoDiagnostics Limited Business Overview
- 8.8.3 ImmunoDiagnostics Limited Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
- 8.8.4 ImmunoDiagnostics Limited Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 8.8.5 ImmunoDiagnostics Limited Recent Developments
- 8.9 Alcyomics Ltd
- 8.9.1 Alcyomics Ltd Company Information
- 8.9.2 Alcyomics Ltd Business Overview
- 8.9.3 Alcyomics Ltd Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
- 8.9.4 Alcyomics Ltd Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 8.9.5 Alcyomics Ltd Recent Developments
- 8.10 IMMUNOLOGIX
- 8.10.1 IMMUNOLOGIX Company Information
- 8.10.2 IMMUNOLOGIX Business Overview
- 8.10.3 IMMUNOLOGIX Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
- 8.10.4 IMMUNOLOGIX Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 8.10.5 IMMUNOLOGIX Recent Developments
- 8.11 Novogene
- 8.11.1 Novogene Company Information
- 8.11.2 Novogene Business Overview
- 8.11.3 Novogene Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
- 8.11.4 Novogene Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 8.11.5 Novogene Recent Developments
- 8.12 Guidon Pharmaceutics
- 8.12.1 Guidon Pharmaceutics Company Information
- 8.12.2 Guidon Pharmaceutics Business Overview
- 8.12.3 Guidon Pharmaceutics Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
- 8.12.4 Guidon Pharmaceutics Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 8.12.5 Guidon Pharmaceutics Recent Developments
- 8.13 MEDx Translational Medicine Co., Ltd
- 8.13.1 MEDx Translational Medicine Co., Ltd Company Information
- 8.13.2 MEDx Translational Medicine Co., Ltd Business Overview
- 8.13.3 MEDx Translational Medicine Co., Ltd Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)
- 8.13.4 MEDx Translational Medicine Co., Ltd Meso Scale Discovery (MSD) Assay Services Product Portfolio
- 8.13.5 MEDx Translational Medicine Co., Ltd Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst